Alto Neuroscience (ANRO) Total Current Liabilities (2023 - 2026)

Alto Neuroscience has disclosed Total Current Liabilities across 4 years of filings, most recently posting $13.1 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $13.1 million, up 80.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.1 million (up 80.72% YoY), and the FY2025 annual result was $11.3 million, up 13.16% from the prior year.
• Total Current Liabilities came in at $13.1 million for Q1 2026 at Alto Neuroscience, up from $11.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $14.0 million in Q3 2024 to a low of $5.6 million in Q4 2023.
• The 4-year median for Total Current Liabilities is $9.4 million (2024), against an average of $9.6 million.
• Across the five-year window, Total Current Liabilities sank 35.46% in 2025 and jumped 80.72% in 2026, its largest moves.
• Alto Neuroscience's Total Current Liabilities stood at $5.6 million in 2023, then surged by 78.4% to $10.0 million in 2024, then advanced by 13.16% to $11.3 million in 2025, then grew by 15.81% to $13.1 million in 2026.
• The last three Total Current Liabilities figures came in at $13.1 million (Q1 2026), $11.3 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.